Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp > OK even with

<< Previous

Bullboard Posts

Next >>

Comment by Iseneschalon Feb 25, 2021 3:14pm

162 Views

Post# 32660395

RE:OK even with

OnlyOIL wrote: the offering 1 common share and 1 warrent still works out to $6.35 per unit So I do beleive we have bottomed

How did you come up with $6.35?

r u saying the unit financing @$4.25 u.s x the cad conversion ?

Please explain... thx

make note : they are "Pre-funded warrants"

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario